Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Gupta

Showing results (771-780 of 834) with videos related to

Pageof 84
Sort By:
Oral Oncology|January 21, 2026
Long-Term outcomes of induction chemotherapy-guided reduced-dose chemoradiotherapy in poor-risk HPV-Positive oropharyngeal Cancer: Results from the sequential quarterback trialsJ T Lovett, M T Wotman, W H Westra, et al.
Clinical and Translational Science|January 26, 2017
Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and LaunchH Scheerens, A Malong, K Bassett, et al.
Oral Oncology|June 17, 2026
Corrigendum to "Long-Term outcomes of induction chemotherapy-guided reduced-dose chemoradiotherapy in poor-risk HPV-Positive oropharyngeal Cancer: Results from the sequential quarterback trials" [Oral Oncol. 174 (2026) 107858]J T Lovett, M T Wotman, W H Westra, et al.
The Lancet. Gastroenterology & Hepatology|October 10, 2024
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 studyMan-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, et al.
American Journal of Hematology|May 26, 2016
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLLIan W Flinn, Panayiotis Panayiotidis, Boris Afanasyev, et al.
Oral Oncology|July 27, 2019
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trialK Misiukiewicz, V Gupta, B A Miles, et al.
The AAPS Journal|April 19, 2011
Characterization of silvestrol pharmacokinetics in mice using liquid chromatography-tandem mass spectrometryU V R Vijaya Saradhi, Sneha V Gupta, Ming Chiu, et al.
Leukemia Research|February 17, 2012
RBC-transfusion guidelines updateR P Gale, G Barosi, T Barbui, et al.
BJU International|January 28, 2020
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertionsRussell W Madison, Sumati V Gupta, Yasir Y Elamin, et al.
Transboundary and Emerging Diseases|February 7, 2019
Phylogenetic analysis of haemagglutinin gene deciphering a new genetically distinct lineage of canine distemper virus circulating among domestic dogs in IndiaM Bhatt, K K Rajak, S Chakravarti, et al.
Pageof 84

Showing results (771-780 of 834) with videos related to

Sort By:
Pageof 84
Oral Oncology|January 21, 2026
Long-Term outcomes of induction chemotherapy-guided reduced-dose chemoradiotherapy in poor-risk HPV-Positive oropharyngeal Cancer: Results from the sequential quarterback trialsJ T Lovett, M T Wotman, W H Westra, et al.
Clinical and Translational Science|January 26, 2017
Current Status of Companion and Complementary Diagnostics: Strategic Considerations for Development and LaunchH Scheerens, A Malong, K Bassett, et al.
Oral Oncology|June 17, 2026
Corrigendum to "Long-Term outcomes of induction chemotherapy-guided reduced-dose chemoradiotherapy in poor-risk HPV-Positive oropharyngeal Cancer: Results from the sequential quarterback trials" [Oral Oncol. 174 (2026) 107858]J T Lovett, M T Wotman, W H Westra, et al.
The Lancet. Gastroenterology & Hepatology|October 10, 2024
VIR-2218 (elebsiran) plus pegylated interferon-alfa-2a in participants with chronic hepatitis B virus infection: a phase 2 studyMan-Fung Yuen, Young-Suk Lim, Ki Tae Yoon, et al.
American Journal of Hematology|May 26, 2016
A phase 2, multicenter study investigating ofatumumab and bendamustine combination in patients with untreated or relapsed CLLIan W Flinn, Panayiotis Panayiotidis, Boris Afanasyev, et al.
Oral Oncology|July 27, 2019
Standard of care vs reduced-dose chemoradiation after induction chemotherapy in HPV+ oropharyngeal carcinoma patients: The Quarterback trialK Misiukiewicz, V Gupta, B A Miles, et al.
The AAPS Journal|April 19, 2011
Characterization of silvestrol pharmacokinetics in mice using liquid chromatography-tandem mass spectrometryU V R Vijaya Saradhi, Sneha V Gupta, Ming Chiu, et al.
Leukemia Research|February 17, 2012
RBC-transfusion guidelines updateR P Gale, G Barosi, T Barbui, et al.
BJU International|January 28, 2020
Urothelial cancer harbours EGFR and HER2 amplifications and exon 20 insertionsRussell W Madison, Sumati V Gupta, Yasir Y Elamin, et al.
Transboundary and Emerging Diseases|February 7, 2019
Phylogenetic analysis of haemagglutinin gene deciphering a new genetically distinct lineage of canine distemper virus circulating among domestic dogs in IndiaM Bhatt, K K Rajak, S Chakravarti, et al.
Pageof 84